Search: onr:"swepub:oai:DiVA.org:uu-4088" >
Cellular Pharmacolo...
Cellular Pharmacology of the Novel Antitumoural Cyanoguanidine CHS 828
-
- Lövborg, Henrik, 1974- (author)
- Uppsala universitet,Institutionen för medicinska vetenskaper
-
Larsson, Rolf (thesis advisor)
-
Nygren, Peter (thesis advisor)
-
show more...
-
- Wiman, Klas, Professor (opponent)
- Institutionen för onkologi-patalogi Karolinska Institutet, Stockholm
-
show less...
-
(creator_code:org_t)
- ISBN 9155459021
- Uppsala : Acta Universitatis Upsaliensis, 2004
- English 31 s.
-
Series: Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, 0282-7476 ; 1330
- Related links:
-
https://uu.diva-port... (primary) (Raw object)
-
show more...
-
https://urn.kb.se/re...
-
show less...
Abstract
Subject headings
Close
- The antitumoural cyanoguanidine CHS 828 has shown promising activity in a number of preclinical and clinical studies. However, the mechanisms underlying the cell death induced by CHS 828 has not been clarified. This thesis describes in vitro studies of the cellular pharmacology of CHS 828.CHS 828 induced cell death with necrosis like features in the lymphoma cell line U-937 GTB. Addition of 3-aminobenzamide, an inhibitor of ADP-ribosylation, resulted in a decreased sensitivity to CHS 828 and a shift in the mode of cell death towards apoptosis. Mouse fibroblasts lacking the enzyme PARP-1 were more sensitive to CHS 828 compared to normal fibroblasts. CHS 828 was able to induce p53 in normal fibroblasts but this effect does not seem to be necessary to induce cell death.Characterization of two CHS 828 resistant cell lines indicated that they were selectively resistant to cyanoguanidines. Known mechanisms of anticancer drug resistance did not seem to account for the cyanoguanidine resistance. One possible resistance mediating protein, which was upregulated in the resistant cells, was epidermal fatty acid binding protein.A novel high content screening assay was also developed. The assay was shown to be suitable both for screening of potential novel antitumoural substances as well for mechanistic studies. In the assay, CHS 828 induced caspase-3 activity and reduction in mitochondrial membrane potential, both signs of apoptosis, in U-937 GTB cells. However, nuclei in exposed cells did not show nuclear fragmentation, one of the hallmarks of apoptosis.CHS 828 was also shown to indirectly inhibit the proteasome activity in U-937 GTB cells. In conclusion, the results presented provide new insights into the metabolic and molecular events involved in cell death induced by CHS 828.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)
Keyword
- Pharmacology
- CHS 828
- Cyanoguanidines
- Oncology
- Pharmacology
- Farmakologi
- Pharmacological research
- Farmakologisk forskning
Publication and Content Type
- vet (subject category)
- dok (subject category)
Find in a library
To the university's database